Arrowhead Pharmaceuticals Inc. (ARWR)
NASDAQ · Healthcare
Arrowhead Pharmaceuticals Inc. Net Income 2011–2025
Arrowhead Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Arrowhead Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -132.7 M, a 135.83% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 93.3 M, a 115.49% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. annual net income for 2025 was -1.6 M, a 99.73% decrease from 2024.
- Arrowhead Pharmaceuticals Inc. annual net income for 2024 was -599.5 M, a 192.04% increase from 2023.
- Arrowhead Pharmaceuticals Inc. annual net income for 2023 was -205.3 M, a 16.59% increase from 2022.
- Arrowhead Pharmaceuticals Inc. annual net income for 2022 was -176.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arrowhead Pharmaceuticals Inc. Net Income — FAQ
Arrowhead Pharmaceuticals Inc. (ARWR) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Arrowhead Pharmaceuticals Inc.'s net income?
Arrowhead Pharmaceuticals Inc. (ARWR) reported net income of -$2M for fiscal 2025.
Where can I see ARWR's net income history?
The chart and table above show Arrowhead Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.